Business Segments · Amortization

MEDTECH — Amortization

Johnson & Johnson MEDTECH — Amortization remained flat by 0.0% to $500.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $500.00M to $500.00M.

Analysis

StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2018
Last reportedQ1 2026Apr 22, 2026

How to read this metric

Higher amortization often reflects significant past acquisition activity or heavy investment in intellectual property.

Detailed definition

This represents the periodic expense recognized for the allocation of the cost of intangible assets, such as patents and...

Peer comparison

Commonly reported as part of segment-level depreciation and amortization in financial disclosures for M&A-active firms.

Metric ID: jnj_segment_medtech_amortization

Historical Data

15 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$300.00M$300.00M$300.00M$300.00M$300.00M$400.00M$400.00M$400.00M$400.00M$400.00M$500.00M$500.00M$500.00M$500.00M$500.00M
QoQ Change+0.0%+0.0%+0.0%+0.0%+33.3%+0.0%+0.0%+0.0%+0.0%+25.0%+0.0%+0.0%+0.0%+0.0%
YoY Change+0.0%+0.0%+33.3%+33.3%+33.3%+0.0%+0.0%+25.0%+25.0%+25.0%+0.0%+0.0%
Range$300.00M$500.00M
CAGR+15.7%
Avg YoY Growth+14.6%
Median YoY Growth+12.5%
Current Streak14+ quarters growth

Frequently Asked Questions

What is Johnson & Johnson's medtech — amortization?
Johnson & Johnson (JNJ) reported medtech — amortization of $500.00M in Q1 2026.
How has Johnson & Johnson's medtech — amortization changed year-over-year?
Johnson & Johnson's medtech — amortization decreased by 0.0% year-over-year, from $500.00M to $500.00M.
What does medtech — amortization mean?
The non-cash expense related to the gradual write-down of intangible assets like patents and acquired technology.